HAIRY CELL LEUKEMIA
Clinical trials for HAIRY CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new HAIRY CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for HAIRY CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare leukemia: targeted pill shrinks tumors in relapsed patients
Disease control CompletedThis study tested a drug called vemurafenib (Zelboraf) in 36 people with hairy cell leukemia that returned or didn't respond to standard treatment. The goal was to see how well the drug could clear leukemia cells from the blood and bone marrow. Results showed that many patients r…
Matched conditions: HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
New drug combo shows promise for blood cancers
Disease control CompletedThis study tested a combination of two drugs, acalabrutinib and pembrolizumab, in 161 people with different types of blood cancers like lymphoma and leukemia. The main goal was to check safety and see how well the treatment works. This is an early-stage study, so results help gui…
Matched conditions: HAIRY CELL LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated May 17, 2026 05:30 UTC
-
New combo aims to beat hairy cell leukemia with fewer side effects
Disease control CompletedThis study tested a new treatment for hairy cell leukemia using two drugs: vemurafenib (a pill) and rituximab (an IV infusion). The goal was to see if this combination works better and causes fewer side effects than standard chemotherapy. The study included 15 adults with hairy c…
Matched conditions: HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Scripps Health • Aim: Disease control
Last updated May 14, 2026 12:02 UTC